ACS Omega
(Feb 2019)
Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy
- Clara T. Schoeder,
- Anne Meyer,
- Andhika B. Mahardhika,
- Dominik Thimm,
- Thomas Blaschke,
- Mario Funke,
- Christa E. Müller
Affiliations
- Clara T. Schoeder
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Anne Meyer
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Andhika B. Mahardhika
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Dominik Thimm
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Thomas Blaschke
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Mario Funke
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- Christa E. Müller
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
- DOI
-
https://doi.org/10.1021/acsomega.8b03695
- Journal volume & issue
-
Vol. 4,
no. 2
pp.
4276
– 4295
WeChat QR code